SCHEMBL21341733

SCHEMBL21341733

CC(=O)n1c(C(C)(C)C)cc2ccc(C(C)(C)C)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ CCR9 P51686 8/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ TDP1 Q9NUW8 3/20 0.36
▸ NR1I2 O75469 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ KCNH2 Q12809 1/20 0.34
▸ POLB P06746 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24944395 0.86 HSP90AA1 (0.36) HSP90AA1HSP90AB1CCR9HDAC10HDAC6
SCHEMBL24943810 0.80 CCR9 (0.37) HSP90AA1HSP90AB1CCR9TDP1KDM4E
SCHEMBL20618778 0.74 KCNH2 (0.41) CCR9HDAC10HDAC6TDP1NR1I2
SCHEMBL21341331 0.74 KDM4E (0.34) HSP90AA1HSP90AB1CCR9TDP1KDM4E
SCHEMBL8957563 0.72 NOTUM (0.54) HSP90AA1HSP90AB1CCR9TDP1ALDH1A1
SCHEMBL21341613 0.70 DHFR (0.45) CCR9TDP1ALDH1A1HPGDALOX15
SCHEMBL21341616 0.70 CCR9 (0.38) CCR9HDAC10HDAC6TDP1NR1I2
SCHEMBL27790682 0.70 POLB (0.66) ALDH1A1HPGDHSD17B10KDM4EPOLB
SCHEMBL24943617 0.69 ALDH1A1 (0.36) CCR9TDP1ALDH1A1HPGDALOX15
SCHEMBL21341612 0.69 CCR9 (0.39) CCR9HDAC10HDAC6TDP1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190276440-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) 2019-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190276440-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF ROCK1, ROCK2, RHOA HSP90AA1 1013/4885HSP90AB1 855/4885CCR9 3518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback